Retrospective multicentre analysis of S.M.A.R.T. vs. luminexx nitinol stent implantation for superficial femoral artery lesions (REAL SL) registry: 5 years' experience

Circulation Journal

Volumn 75, Issue 2, 2011, Pages 421-427

  Iida, Osamu ^a   Soga, Yoshimitsu ^b   Hirano, Keisuke ^c   Okamoto, Shin ^a   Dohi, Tomoharu ^a   Uematsu, Masaaki ^a   Yokoi, Hiroyoshi ^b   Nobuyoshi, Masakiyo ^b   Muramatsu, Toshiya ^c   Fujita, Masashi ^a   Nanto, Shinsuke ^a   Nagata, Seiki ^d  

^a KANSAI ROSAI HOSPITAL   (Japan)

^b KOKURA MEMORIAL HOSPITAL   (Japan)

^c SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Peripheral arterial disease; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; NITINOL; TICLOPIDINE;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT PATENCY; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSTHESIS FAILURE; RETROSPECTIVE STUDY; STENT; SUPERFICIAL FEMORAL ARTERY;

ALLOYS; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; EQUIPMENT FAILURE; FEMORAL ARTERY; HUMANS; LIMB SALVAGE; PREVALENCE; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; STENTS; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 79251582533     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0741     Document Type: Article

References (19)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S296.
2. Nogren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 43: S1-S67.
3. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888.
4. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized, multicenter study comparing expanded polytetrafluoroethylene- covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-832.
5. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation 2007; 116: 285-292.
6. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009; 74: 1090-1095.
7. Ranke C, Creutzig A, Alexander K. Duplex scanning of peripheral arteries: Correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992; 18: 433-440.
8. Dormandy J, Mahir M, Ascady G, Balsano F, De Leeuw P, Blombery P, et al. Fate of the patient with chronic leg ischaemia: A review article. J Cardiovasc Surg 1989; 30: 50-57.
9. Daskalopoulou SS, Pathmarajah M, Kakkos SK, Daskalopoulos ME, Holloway P, Mikhailidis DP, et al. Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J 2008; 72: 441-448.
10. Hoshino J, Ubara Y, Ohara K, Ohta E, Suwabe T, Higa Y, et al. Changes in the activities of daily living (ADL) in relation to the level of amputation of patients undergoing lower extremity amputation for arteriosclerosis obliterans (ASO). Circ J 2008; 72: 1495-1498.
11. Pentecost MJ, Criqui MH, Dorros G, Goldstone J, Johnston KW, Martin EC, et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. Circulation 1994; 89: 511-531.
12. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: Propensity scoreadjusted analysis. Radiology 2004; 232: 516-521.
13. Kawamura Y, Ishii H, Aoyama T, Tanaka M, Takahashi H, Kumada Y, et al. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched analysis. J Vasc Surg 2009; 50: 1057-1062.
14. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T, et al. Long-term results of endovascular therapy with nitinol stent implantation for TASC II A/B femoro-popliteal artery lesions: 4 years' experience. Circ J 2009; 73: 2143-2147.
15. Kim SJ, Kim W, Kim JB, Hong MJ, Kang WY, Hwang SH, et al. Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease. Circ J 2010; 74: 1959-1964.
16. Duda SH. The SUPER-SL Study, Multi-center, Head-to-Head Comparison of the S.M.A.R.T.®CONTROL Nitinol Stent (Cordis®) with the Luminexx 6F Stent (Bard®) for the Treatment of Long- TASC C & D Superficial Femoral Artery Lesions. LINC 2009.
17. Minar E, Schillinger M. New stents for SFA. J Cardiovasc Surg 2009; 50: 635-645.
18. Scheinert D, Scheinert S, Sax J, Piorkowski C, Bräunlich S, Ulrich M, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45: 312-315.
19. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W, et al. Frequency of stent fracture as a cause of coronary restenosis after sirolimus- eluting stent implantation. Am J Cardiol 2007; 100: 627-630.